EGFR and ovarian carcinoma: Based on these critical roles of CXCL8 and CCL20, high-grade ovarian cancer cells with abundant TNF and EGFR activation may augment these proinflammatory chemokines to provide an inflammatory tumor microenvironment promoting cancer progression and leading to poorer outcomes and an increase in cancer deaths (Figure 8).